PlainRecalls
FDA Drug Moderate Class II Terminated

DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceuticals Inc, Oklahoma City, OK 73127, NDC: 43063-877-90

Reported: January 1, 2025 Initiated: December 4, 2024 #D-0163-2025

Product Description

DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceuticals Inc, Oklahoma City, OK 73127, NDC: 43063-877-90

Reason for Recall

CGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Duloxetine above the interim acceptable intake limit

Details

Units Affected
70, 90-count bottles
Distribution
Distributed within US: FL, MS, WI
Location
Oklahoma City, OK

Frequently Asked Questions

What product was recalled?
DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceuticals Inc, Oklahoma City, OK 73127, NDC: 43063-877-90. Recalled by PD-Rx Pharmaceuticals, Inc.. Units affected: 70, 90-count bottles.
Why was this product recalled?
CGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Duloxetine above the interim acceptable intake limit
Which agency issued this recall?
This recall was issued by the FDA Drug on January 1, 2025. Severity: Moderate. Recall number: D-0163-2025.